Source: oneinchpunch/Shutterstock.com
It’s time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Moving stocks this morning are study results, earnings reports, and more.
Let’s get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Tenax Therapeutics (NASDAQ:TENX) stock is rocketing more than 134% after for a new patent.
- ZyVersa Therapeutics (NASDAQ:ZVSA) shares are taking off over 117% after filing a .
- Biophytis (NASDAQ:BPTS) stock is surging close to 67% after announcing .
- Lannett (NYSE:LCI) shares are soaring more than 42% with the release of its .
- Bed Bath & Beyond (NASDAQ:BBBY) stock is increasing over 37% after .
- Agile Therapeutics (NASDAQ:AGRX) shares are gaining roughly 37% after providing a .
- Catalyst Biosciences (NASDAQ:CBIO) stock is rising more than 20% alongside heavy pre-market trading.
- EBET (NASDAQ:EBET) shares are getting an almost 20% boost after .
- Edible Garden (NASDAQ:EDBL) stock is jumping over 19% after .
- Meta Platforms (NASDAQ:META) shares are up more than 9% with the release of its .
10 Top Losers
- TeraWulf (NASDAQ:WULF) stock is crashing about 34% due to a .
- OncoSec Medical (NASDAQ:ONCS) shares are diving over 24% after .
- Golden Sun Education (NASDAQ:GSUN) stock is plummeting more than 22% after a massive rally yesterday.
- TransCode Therapeutics (NASDAQ:RNAZ) shares are taking an over 22% beating following a rally yesterday on study results.
- Versus Systems (NASDAQ:VS) stock is tumbling nearly 20% after rallying on partnership news yesterday.
- Motorsport Games (NASDAQ:MSGM) shares are retreating more than 16% following a rally this week.
- Mobile Global Esports (NASDAQ:MGAM) stock is pulling back over 15% following heavy trading yesterday.
- AnPac Bio-Medical Science (NASDAQ:ANPC) shares are falling more than 14% on Thursday morning.
- Cemtrex (NASDAQ:CETX) stock is sliding over 14% after boosted its share price.
- Vera Therapeutics (NASDAQ:VERA) shares close out our pre-market stock movers down more than 12% after .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
